Laid off from Bio-Rad.

What Bio-Rad layoffs have meant for employees

Bio-Rad has described every plan it announced since 2019 as part of one ongoing program, and the plans have come close together. The program, to improve operating performance, is named in the November 2019 8-K, the February 2021 8-K and the February 2025 8-K, and the July 2026 8-K adds strengthening the company's competitive position. Three more plans, approved in 2023, appear in the restructuring note of the 2023 10-K. On the August 4, 2026 call, chief executive Norman Schwartz said Bio-Rad had completed a restructuring program in 2025, in the same remarks in which he turned to the plan announced that week. For anyone deciding whether to stay through a plan or start looking elsewhere, that pace is part of the calculation.

Bio-Rad has said some of its cuts would come with reinvested savings or new roles. The November 2019 8-K said a significant portion of that plan's net savings would be repurposed in line with the company's portfolio strategy, and the February 2021 8-K counted about 325 new positions against the roughly 530 that plan set out to eliminate. On the August 4 call, Roop Lakkaraju, the chief financial officer, said the 2026 restructuring in Bio-Rad's functional operating-expense areas involves headcount reductions, facility rationalization and adding critical skills in support of growth and innovation. The third-quarter 10-Q splits the July plan's termination benefits by segment, $46.4 million in Clinical Diagnostics and $26.3 million in Life Science as of September 30. Those are dollar totals for a worldwide plan, so they can't be read as job counts, but if you work in Clinical Diagnostics, more of the plan's termination money so far has been booked in your segment.

Outside the US, Bio-Rad has tied parts of its plans to local process. The July 2026 8-K says its estimates for headcount reduction, timing and charges in certain areas of the international business are subject to the completion of local employee consultations, and the 2023 10-K says the timing of remaining termination payments under the 2021 plan and two of the 2023 plans follows statutory requirements. For staff in those international areas, the company's own estimates aren't final until that consultation is complete.

Applying the 2025 plan's target to the roughly 7,700 employees Bio-Rad described in a February 13, 2025 release, days after that plan began, gives about 385 people, roughly three times the 131 jobs on the California notices dated three days after it started. Each of those notices gave April 11 as its effective date, 60 days after the February 10 date it carried, by the state's WARN report. For the Hercules, Pleasanton and Richmond jobs on those notices, our California unemployment benefits page explains the state's claim rules, and our unemployment benefits by state page covers the other states. If a package you're offered includes continued US employer health coverage, how COBRA works explains that option.

The facility closures are what draw out the 2026 plan, which Bio-Rad expects to have substantially finished by the time fiscal 2027 ends. Lakkaraju said on the August call that facility exits are the most significant driver of that timeline and could move it a little ahead or a little behind, though he expected all of it finished by the end of 2027 at the latest. If your site is closing, it's worth treating the date you're given as the company's current plan, since its finance chief has said those dates can shift.